‘Important’ Alzheimer’s Treatment Breakthrough Gets FDA Approval
The U.S. Food and Drug Administration (FDA) approved the first blood test to detect Alzheimer's disease in what federal officials called an "important step"...
Baby saved by breakthrough gene-editing treatment
K.J. was diagnosed with a rare genetic disorder. Thanks to a highly personalized genetic treatment, he and his doctors have blazed a new trail...
Belite Bio Announces FDA Granting of Breakthrough Therapy
Designation is based on the pivotal Phase 3 DRAGON trial interim analysis results demonstrating Tinlarebant’s efficacy and favorable safety profileTrial completion expected by Q4...
FDA Approves Breakthrough Breast Cancer Drug With Dual Indications
HONG KONG, May 15, 2025 /PRNewswire/ -- On May 15, 2025, the latest announcement released by the National Medical Products Administration attracted widespread attention...
New NCInnovation grant supports breakthrough Alzheimer’s treatment development at UNC Pembroke
Dr. Ben Bahr, the William C. Friday Chair and Distinguished Professor of Microbiology and Biochemistry at the University of North Carolina at Pembroke, is...
BridgeBio’s Acoramidis: A Breakthrough in ATTR-CM Treatment
On May 19, BridgeBio Pharma, Inc.
Source link
A breakthrough for baby KJ
Baby KJ Muldoon is alive today because of a historic breakthrough in customized gene therapy. Having exhausted conventional treatments, doctors recommended putting KJ on...
